Skip to content

The PHOENIX-HF Cohort Study

The PHOENIX-HF Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114793
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Observation group:none

Sponsors

The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old, gender is not limited. 2. Meet the diagnostic criteria for heart failure stipulated in the guidelines "Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024" and the "National Heart Failure Guidelines". 3. The patient is followed up after treatment and the data is complete. 4. Agree to accept blood, urine, and stool sample collection, complete imaging examinations, and undergo special evaluations of this trial. 5. Patients or their families can understand the study protocol and are willing to participate in this study, and sign a written informed consent form; 6. The patient has good compliance and voluntarily accepts follow-up, treatment, laboratory examination and other research steps as planned.

Exclusion criteria

Exclusion criteria: 1. Complex or special cardiac conditions: (1) Complex congenital heart disease (e.g., Tetralogy of Fallot, uncorrected); (2) Active endocarditis, constrictive pericarditis, Takotsubo cardiomyopathy; (3) Tachycardia-induced cardiomyopathy (where uncontrolled tachycardia is the primary cause, e.g., sustained heart rate >120 beats per minute). 2. Follow-up or compliance issues: (1) Severe mental illness or cognitive impairment (e.g., dementia, schizophrenia) precluding understanding of the study protocol or participation in follow-up; (2) Alcohol or substance abuse affecting compliance. 3. Pregnant or breastfeeding women; 4. Other circumstances deemed unsuitable for study participation by the investigator.

Design outcomes

Secondary

MeasureTime frame
All-cause mortality;The composite endpoint of cardiovascular death and hospitalisation for heart failure.;Incidence of non-fatal myocardial infarction events;Incidence of non-fatal stroke events;Incidence of renal function deterioration events;The incidence rate of acute kidIncidence of acute kidney injury (AKI) events.ney injury (AKI) events in patients with heart failure during follow-up up to 1 month, 6 months, and then annually until the 10th year.;

Primary

MeasureTime frame
All-cause mortality;

Countries

China

Contacts

Public ContactKun Lian

The First Affiliated Hospital of Air Force Military Medical University

liank1122@163.com+86 177 9239 8286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026